この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/1/311 分で読めます
Opportunity for a License: Assay To Screen Inhibitors of HIV-1 Aspartyl Protease
ローカル自動翻訳 · 情報源の原言語
概要
The National Institutes of Health desires to license (in accordance with 35 U.S.C. 207) a novel radiometric assay system for identifying potential new anti-retroviral drugs that target HIV-1 aspartyl proteinase. This retroviral proteinase processes viral proteins and permits their assembly into the structural components of the infectious HIV-1 virions. If this enzyme activity can be inhibited, no mature infectious viral particles are produced.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →